RecallDepth
Class II Ongoing

Duloxetine Delayed-Release Capsules, USP, 60 mg, a.) 90-count bottle (NDC: 51991-748-90), b.)1000-count bottle (NDC 51991-748-10),Rx Only, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain; Dist. by: Breckenridge Pharmaceutical, Inc., Berkeley Heights, NJ 07922.

Company
Breckenridge Pharmaceutical, Inc.
Recall Initiated
October 9, 2025
Posted
November 5, 2025
Recall Number
D-0100-2026
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
172,263 bottles
Firm Location
Berkeley Heights, NJ, United States

Reason for Recall

CGMP Deviations: N-nitroso-duloxetine impurity above the safety assessment limit of 12.5ppm.

Distribution

U.S. Nationwide

Lot / Code Info

90-count- Lot # 240721C; Exp. 02/28/2027 1000-count- Lot #230286C; Exp.02/28/2026

More recalls by Breckenridge Pharmaceutical, Inc.

View all recalls by this company →

Other recent Class II Drug recalls